JENNIFER VEGA: Open Payments
NPI 1609384981 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,639 in 183 payments from 24 companies in 2025. Trend: 2023 $3,769 · 2024 $4,177 · 2025 $3,639
Food & beverage: $3,639
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 35 | $683 |
| ABBVIE INC. | 29 | $538 |
| UCB, Inc. | 27 | $430 |
| Novartis Pharmaceuticals Corporation | 23 | $389 |
| Janssen Biotech, Inc. | 15 | $318 |
| Aurinia Pharma U.S., Inc. | 10 | $221 |
| GENZYME CORPORATION | 8 | $214 |
| Mallinckrodt Hospital Products Inc. | 4 | $116 |
| ANI Pharmaceuticals, Inc. | 5 | $114 |
| GlaxoSmithKline, LLC. | 5 | $109 |
Products named: SKYRIZI, Bimzelx, COSENTYX, TREMFYA, KRYSTEXXA, LUPKYNIS, KEVZARA, UPLIZNA.
Industry payments across FL — which companies pay providers there.
